Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 3;314(17):1869-71.
doi: 10.1001/jama.2015.10347.

Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014

Robert D Kirkcaldy  1 , Edward W Hook 3rd  2 , Olusegun O Soge  3 , Carlos del Rio  4 , Grace Kubin  5 , Jonathan M Zenilman  6 , John R Papp  1
Affiliations

Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014

Robert D Kirkcaldy et al. JAMA. .
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
Percentage of urethral Neisseria gonorrhoeae isolates with reduced cefixime susceptibility (minimum inhibitory concentrations ≥0.25 μg/ml) or reduced ceftriaxone susceptibility (minimum inhibitory concentrations ≥0.125 μg/ml) by year, Gonococcal Isolate Surveillance Project, 2006–2014. NOTE: cefixime susceptibility not tested in 2007 and 2008 MIC=minimum inhibitory concentration Trend of percentage with elevated cefixime MICs from 2006–2011 (p<0.001); 2011–2013 (p<0.001), 2013–2014 (p=0.02 by chi-square) Trend of percentage with elevated ceftriaxone MICs from 2006–2011 (p<0.001); 2011–2013 (p<0.001), 2013–2014 (p=0.13 by chi-square)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Centers for Disease Control and Prevention. Update to CDC’s sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins are no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012;61:590–594. - PubMed
    1. [accessed January 14, 2015];Gonococcal Isolate Surveillance Project (GISP) Protocol. Available at http://www.cdc.gov/std/gisp/gisp-protocol-oct-2014.pdf.
    1. Ison CA, Town K, Obi C, Chisholm S, Hughes G, Livermore DM, et al. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007–2011. Lancet Infect Dis. 2013;13:762–768. - PubMed
    1. European Centre for Disease Prevention and Control. [accessed May 8, 2015];Gonococcal antimicrobial susceptibility in Europe —2012. Available at: http://ecdc.europa.eu/en/publications/Publications/gonococcal-antimicrob....
    1. Kidd S, Lee MV, Maningas E, Komeya A, Kunimoto G, O’Connor N, et al. Gonococcal susceptibility to cephalosporins—Hawaii, 2003 to 2011. Sex Transm Dis. 2013;40(9):756–759. - PMC - PubMed

Publication types